Tumor Necrosis Factor α and Colitis-Associated Colon Cancer
Tumor Necrosis Factor α and Colitis-Associated Colon Cancer Clinical Implications of Basic Research, N Engl J Med 2008:358;2733-2734.. In the first sentence of the fourth paragraph (page 2733), etanercept should have been described as “a human TNF-α antagonist (a fusion protein of the ligand-binding...
Gespeichert in:
Veröffentlicht in: | The New England journal of medicine 2008-12, Vol.359 (26), p.2853-2853 |
---|---|
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Tumor Necrosis Factor α and Colitis-Associated Colon Cancer Clinical Implications of Basic Research, N Engl J Med 2008:358;2733-2734.. In the first sentence of the fourth paragraph (page 2733), etanercept should have been described as “a human TNF-α antagonist (a fusion protein of the ligand-binding portion of the human p75 TNF receptor with the Fc portion of human IgG1)” rather than as “a monoclonal antibody that binds TNF-α.” The article has been corrected on the
Journal
's Web site at www.nejm.org. |
---|---|
ISSN: | 0028-4793 1533-4406 |
DOI: | 10.1056/NEJMx080040 |